key: cord-1020754-dyy7ghem
authors: Davenport, Matthew S.; Fruscello, Tom; Chatfield, Mythreyi; Weinstein, Stefanie; Sensakovic, William F.; Larson, David B.
title: Computed Tomography Volumes from 2,398 Radiology Practices in the United States:A Realtime Indicator of the Effect COVID-19 on Routine Care, January to September 2020
date: 2020-10-21
journal: J Am Coll Radiol
DOI: 10.1016/j.jacr.2020.10.010
sha: f86deb3c8c03c2a04e31e8b4daf08fb134985881
doc_id: 1020754
cord_uid: dyy7ghem

Purpose To determine the effect of coronavirus disease 2019 (COVID-19) on CT volumes in the United States during and following the first wave of the pandemic. Methods CT volumes from 2,398 United States radiology practices participating in the American College of Radiology (ACR) Dose Index Registry from January 1, 2020 to September 30, 2020 were analyzed. Data were compared to projected CT volumes using 2019 normative data, and analyzed with respect to time since government orders, and population-normalized positive COVID-19 tests and attributed deaths. Data were stratified by state population density, unemployment status, and race. Results There were 16,198,830 CT examinations (2,398 practices). Volume nadir occurred an average of 32 days after each state-of-emergency declaration and 12 days after each stay-at-home order. At nadir, the projected volume loss was 38,043 CTs per day (of 71,626 CTs/day; 53% reduction). Over the entire study period, there were 3,689,874 less CT examinations performed than predicted (of 18,947,969; 19% reduction). There was less reduction in states with smaller population density (15% [169,378/1,142,247; Quartile 1] vs. 21% [1,894,152/9,140,689; Quartile 4]) and less reduction in states with a lower insured unemployed proportion (13% [279,331/2,071,251; Quartile 1] vs. 23% [1,753,521/7,496,443; Quartile 4]). By September 30, CT volume had returned to 84% (59,856/71,321) of predicted; recovery of CT volume occurred as positive COVID-19 tests rose and deaths were in decline. Conclusion COVID-19 substantially reduced United States CT volume, reflecting delayed and deferred care, especially in states with greater unemployment. Partial volume recovery occurred despite rising positive COVID-19 tests.

In early 2020, the coronavirus disease 2019 (COVID-19) pandemic began spreading rapidly across the United States, causing death; critical illness; shortages in peronal protective equipment (PPE); capacity constraints in hospitals, intensive care units, and ventilators; and widespread financial and societal disruption [1] [2] [3] [4] [5] . Health care systems and governments responded by restricting access to routine (i.e., non-urgent) medical care [5] [6] [7] [8] [9] . The belief was that performing routine care could consume resources and leave facilities unable to care for the unknown number of future patients with COVID-19.

Additionally, it was unclear whether it would be safe to care for patients with contagious yet potentially unknown COVID-19 at a time when routine testing was not available, effective treatment was uncertain, and best practices for PPE were in flux. These actions were deemed necessary at the time, but carried the potential for paradoxical unintended harm from delayed or deferred care [9] [10] [11] . Determining the optimal time to re-engage routine care while balancing these competing issues was critical [1, 3, [5] [6] [9] [10] [11] .

Early data, based primarily on single-or multi-institutional reports with small numbers of participating institutions, indicated the first wave of the COVID-19 pandemic led to expected marked reductions in routine care [6] [7] [8] . However, the specific effects by state with reference to governmental executive orders, positive COVID- 19 15] from January 1, 2020 to September 30, 2020 were analyzed. January 1, 2020 was chosen as a start date to provide a baseline period prior to the pandemic. September 30, 2020 was chosen as an end date to reflect data during and following the first wave of the pandemic. CT volume data were assessed with respect to time since state stay-at-home order, time since state state-ofemergency declaration, and population-normalized positive COVID-19 tests and attributed deaths.

The Dose Index Registry was launched by the ACR in 2011 [12] [13] [14] [15] . It receives data on over 20 million examinations per year from participating practices. Once a practice has voluntarily initiated participation (nominal annual fee), daily practice meta-data and CT dose index data for all CT examinations performed contemporaneously at that site are automatically transmitted to the ACR [12] [13] [14] [15] . Although the primary purpose of the Dose Index Registry is to monitor and compare radiation doses, the registry can be used as a strong and robust realtime sample of CT imaging volumes across the United States.

Additional sources of data included: a) Positive COVID-19 test volume by state (Data.World) [16] J o u r n a l P r e -p r o o f b) Deaths attributed to COVID-19 by state (Data.World) [16] c) State population densities (United States Census Bureau) [17] d) State populations (United States Census Bureau) [18] e) Weekly insured unemployed proportion (United States Department of Labor) [19] f) Estimated total United States CT volume for 2019 (Amber Diagnostic) [20] g) Statewise state-of-emergency orders, stay-at-home orders, and reopening dates (New York Times) [21] h) State populations in urban areas and urban clusters (United States Census Bureau) [22] i) State populations by race (United States Census Bureau) [23] Statistical Analysis CT imaging volumes from January 1, 2020 to September 30, 2020 submitted to the ACR Dose Index Registry were compared to projected CT volumes using 2019 CT Dose Index Registry normative data. Projected volumes were from sites that submitted data in 2019 for the same time period, by day, with an assumed 3% annual growth rate.

Data were analyzed with respect to time since state stay-at-home order, time since state-ofemergency declaration, and population-normalized positive COVID-19 tests and attributed deaths. Data State-level analyses were considered to have insufficient data if there were fewer than 6 reporting facilities or if there were fewer than an average of 100 CT examinations submitted per day during the reporting period.

Practice locations that joined the Dose Index Registry after January 2019 were not included in the estimates of CT volume lost.

There were 16, 198 ,830 CT examinations analyzed from 2,398 practices, including 9,224,549 in metropolitan centers, 5,091,059 in suburban centers, and 1,883,222 in rural centers [ Table 1 ]. Only 2.2% (53/2,398) were pediatric hospitals; 29% (693/2,398) had a trauma center designation [ Table 1 ].

CT volume nadir occurred an average of 32 days after each statewide state-of-emergency declaration and 12 days after each statewide stay-at-home order [ Figure 1 ]. At the nadir, the projected volume loss was 38,043 CTs per day (of 71,626 CTs/day; 53% reduction) [ Figure 2 ]. Over the entire study period, there were 3,689,874 less CT examinations performed than predicted (of 18,947,969 predicted; 19% reduction). On September 30, CT volume was 84% (59,856/71,321) of predicted. Recovery of CT volume occurred as positive COVID-19 tests rose and deaths were in decline, and was maintained despite COVID-19-attributed deaths rising a second time [ Figure 1 ]. In general, there was no particular relationship between statewide CT volumes and statewide local COVID-19 incidence [ Figure 3 ]. Once CT volumes recovered (June to July 2020), they remained in plateau below pre-pandemic levels through the end of the study period (September 2020) [ Figure 1 ]. 

The first wave of the COVID-19 pandemic substantially reduced CT imaging volume in the United States, likely reflecting a combination of delayed and deferred routine care. At its nadir (average: 32 days after each statewide state-of-emergency declaration, 12 days after each statewide stay-at-home order), daily CT volume had been reduced by 53%. All states and practice types were severely affected, though states with greater population density and more unemployment experienced more of a decline in CT volume than states with less pouplation density or less unemployment. Incomplete CT volume recovery followed, slower than the initial decline, and remained steady across the country despite an increase in the number of positive COVID-19 tests, and increased deaths after the initial wave. By September 30, 2020, CT volume was 84% of predicted based on 2019 normative data, and was in plateau. The reason for the incomplete recovery is unclear and not explainable by our results, but probably relates to the ongoing pandemic and fear about safe re-engagement of routine care. These data are potentially important because CT is a common diagnostic tool for many clinical indications and J o u r n a l P r e -p r o o f has a substantial effect on clinical decision-making [24] [25] . It is probable that the prevalence of non-COVID-19 disease that would be detected by CT did not meaningfully change during the reduction in services, indicating that diagnoses were likely delayed or misdirected during the period of suppression.

The fact that CT volume never recovered to predicted levels suggests that a substantial proportion of reduced care likely was not just deferred, but was not provided at all.

Large reductions in diagnostic and interventional radiology volumes have been reported elsewhere in community and academic sites [26] [27] [28] [29] [30] . Naidich et al [27] reported imaging volumes within a large New York health system during a 16-week period from January 1, 2020 to April 18, 2020, and found a 12.29% decline in overall imaging weeks 1-16 and an 88% decline in outpatient imaging during week 16. These data were corroborated by Duszak et al [30] , who assessed imaging metadata from 9

United States community hospitals January 2019 to May 2020 and found that overall imaging volume was 52% less than predicted during the volume nadir. Kansagra et al [28] analyzed data on 231,753 patients from 856 United States hospitals July 1, 2019 to April 27, 2020 and found that imaging for stroke declined by 39% (1.18 patients per day per hospital to 0.72 patients per day per hospital) in the early-pandemic epoch, indicating that urgent care likely was being affected in addition to routine care during the first wave of the pandemic. Each of these studies [27] [28] 30] showed the intial decline we observed, but did not include statewide analysis or a recovery period assessment, or show relationships to COVID-19 data.

When considering the cessation or re-engagement of routine medical care during the course of a pandemic, the following principle should be followed: "if the risk of illness or death to a health care worker or patient from health care-acquired COVID-19 is greater than the risk of illness or death from delaying [care], the care should be delayed; however, if the opposite is true, the [care] should proceed in a timely fashion" [6] . In the early days of the COVID-19 pandemic, risk-benefit calculations were J o u r n a l P r e -p r o o f fraught by insufficient data. Therefore, an aggressive conservative approach was assumed and much routine care was discontinued abruptly by health care systems, governments, and patients [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . The rationale was complex but generally reflected: (1) a desire to avoid overburdening intensive care units and hospital beds in anticipation of a surge of critically ill patients, and (2), a desire to avoid transmitting COVID-19 to patients or to healthcare workers.

As the indirect harms of routine care discontinuation were felt (i.e., lapses in cancer detection, stage migration, delayed presentation of cardiovascular illnesses) [31] [32] [33] [34] [35] [36] , and the attributed deaths from COVID-19 declined [16] , health care systems attempted to safely re-engage care despite a rising number of positive COVID-19 tests [16] . This re-engagement of routine care was further motivated by financial considerations. In the United States, where health care is largely privatized, a side effect of discontinuation was severe economic strain on health care systems and their employees, resulting in billions of dollars of losses across the sector and employment contraction [6, 37] . Whether re-engaging care was safe was unclear at the time it occurred [6] . However, data have since shown the risk to patients interacting with ambulatory health care facilities during the COVID-19 pandemic is probably low [38] . Our study has potential limitations. The start and end dates of the study period were partially arbitrary and designed to incorporate dates before, during, and after the first wave of the COVID-19 pandemic. COVID-19 testing capacity changed across the country during the study period. Absolute numbers of positive COVID-19 tests do not directly indicate disease prevalance. Accurate determination of COVID-19 attributable deaths is complicated for a variety of reasons, and thus the death data we J o u r n a l P r e -p r o o f analyzed are not likely to be accurate; however, the trends are likely to be [39] [40] . There was statewide variation in the number of radiology practices participating in the ACR CT Dose Index Registry, and in the quality and accuracy of COVID-19 reporting. This heterogeneity impairs the accuracy of state-by-state comparisons. However, the large sample size (2,398 practices; 16,198,830 CTs) and national sample provides a robust estimate of CT use across the United States.

In conclusion, the first wave of the COVID-19 pandemic substantially reduced CT imaging volume in the United States due to delayed and deferred care, especially in states with greater unemployment. This was followed by broadbased but slower and incomplete volume recovery that occurred despite rising positive COVID-19 tests. At the conclusion of the study period, CT volume was 84% of predicted and in plateau. The incomplete blunted recovery likely is due to many factors, including but not limited to: (1) safety concerns of patients and healthcare workers regarding re-engaging routine care, (2) Nationwide relationship between CT imaging volume (blue lines; 7-day moving averages) and COVID-19-attributed deaths (top, gray bars, normalized per 100,000 people), COVID-19 positive tests (middle, orange bars, normalized per 100,000 people), and state government executive orders (bottom). Data are from January 1, 2020 to September 30, 2020. The "notches" in CT volume during the months of May, July, and September correspond to 3-day Memorial Day, July 4 th , and Labor Day weekends, and also occurred in 2019 [ Figure 2 ]. 

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Estimating the burden of United States workers exposed to infection or disease: a key factor in containing risk of COVID-19 infection

Using social and behavioural science to support COVID-19 pandemic response

Centers of Disease Control and Prevention. Coronavirus disease 2019 (COVID-19

Reopening society and the need for real-time assessment of COVID-19 at the community level

ACR statement on safe resumption of routine radiology care during the coronavirus disease 2019 (COVID-19) pandemic

COVID-19 pandemic impact on decreased imaging utilization: a single institutional experience

Characteristics of COVID-19 community practice declines in non-invasive diagnostic imaging professional work

The untold toll-the pandemic's effects on patients without COVID-19

Forced choices: ethical challenges in cardiology during the COVID-19 pandemic

Fewer hospitalizations for actue cardiovascular conditions during the COVID-19 pandemic

The ACR Computed Tomography Dose Index Registry: the 5 million examination update

ACR dose index registry

Implementation of the ACR Dose Index Registry

Data.world. COVID-19 positive tests and deaths by state

United States Census Bureau. 2010 census: population density data

United States Census Bureau. Population, population change, and estimated components of population change

Unemployment insurance weekly claims data

CT procedure volume hit all-time high in 2019

See how all 50 states are reopening (and closeing again

Population Subjects Summarized to the Block Level, P2. Urban and Rural, Decennial Census

Age, Sex, Race, and Hispanic Origin -6 race groups (5 race alone groups and one multiple race group) (SC-EST2019-ALLDATA6)

Changes in physician decision making after CT: a prospective multicenter study in primary care settings

CT in the emergency department: a real-time study of changes in physician decision making

Changes in internvetional radiology practice in a tertiary academic center in the United States during the coronavirus disease 2019 (COVID-19) pandemic

Impact of the coronavirus disease 2019 (COVID-19) pandemic on imaging case volumes

Collateral effect of COVID-19 on stroke evaluation in the United States

Characteristics of coronavirus disease 2019 (COVID-19) community practice declines in noninvasive diagnostic imaging professional work

Variables influencing radiology volume recoverty during the next phase of the coronavirus disease 2019 (COVID-19) pandemic

The health impact of the 2014-2015 Ebola outbreak

Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study

Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology

Impact of COVID-19 pandemic on patients with STsegment elevation myocardial infarction: insights from a British cardiac center

Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic

Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during the COVID-19 pandemic

Special report of the RSNA COVID-19 Task Force: the short and long-term financial impact of the COVID-19 pandemic on private radiology practices

Assocation between number of in-person health care visits and SARS-CoV-2 infection in obstetrical patients

Excess deaths from COVID-19 and other causes

Estimation of excess deaths associated with the COVID-19 pandemic in the United States

This research was supported by the American College of Radiology's National Radiology Data Registry (NRDR). The authors wish to thank ACR staff for assistance in preparation of the Dose Index Registry data and acknowledge guidance and input by the NRDR steering committee for this analysis.